Erythropoietin receptor expression in canine mammary tumor: An immunohistochemical study

Veterinary Pathology

Volumn 42, Issue 6, 2005, Pages 837-840

  Sfacteria, A ^a   Mazzullo, G ^b   Bertani, C ^b   Calabro P ^b   De Vico, G ^b   Macri B ^b  

^a UNIVERSITY OF MESSINA   (Italy)

^b NONE

Author keywords

Dogs; Erythropoietin; Erythropoietin receptor; Mammary gland tumor

Indexed keywords

ERYTHROPOIETIN RECEPTOR;

ANIMAL; ANIMAL DISEASE; ARTICLE; COMPARATIVE STUDY; DOG; DOG DISEASE; EXPERIMENTAL NEOPLASM; FEMALE; GENE EXPRESSION REGULATION; IMMUNOHISTOCHEMISTRY; METABOLISM;

ANIMALS; DOG DISEASES; DOGS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; IMMUNOHISTOCHEMISTRY; MAMMARY NEOPLASMS, ANIMAL; RECEPTORS, ERYTHROPOIETIN;

CANIS FAMILIARIS;

EID: 28144441597     PISSN: 03009858     EISSN: 03009858     Source Type: Journal    
DOI: 10.1354/vp.42-6-837     Document Type: Article

References (14)

1. Acs G, Zhang PJ, Rebbeck TR, Acs P, Verma A: Immunohistochemical expression of erythropoietin and erythropoietin receptor in breast carcinoma. Cancer 95:969-981, 2002
2. Bernaudin M, Marti HH, Roussel S, Divoux D, Nouvelot A, MacKenzie ET, Petit E: A potential role for erythropoietin in focal permanent cerebral ischemia in mice. J Cereb Blood Flow Metab 19:643-651, 1999
3. Campana WM, Myers RR: Erythropoietin and erythropoietin receptors in the peripheral nervous system: changes after nerve injury. Faseb J 15:1804-1806, 2001
4. Dawson TM: Preconditioning-mediated neuroprotection through erythropoietin? Lancet 359:96-97, 2002
5. Goldberg MA, Dunning SP, Bunn HF: Regulation of the erythropoietin gene: evidence that the oxygen sensor is a heme protein. Science 242:1412-1415, 1988
6. Grasso G, Buemi M, Alafaci C, Sfacteria A, Passalacqua M, Sturiale A, Calapai G, De Vico G, Piedimonte G, Salpietro FM, Tomasello F: Beneficial effects of systemic administration of recombinant human erythropoietin in rabbits subjected to subarachnoid hemorrhage. Proc Natl Acad Sci USA 99:5627-5631, 2002
7. Grasso G, Sfacteria A, Passalacqua M, Morabito A, Buemi M, Macrì B, Brines ML, Tomasello F: Erythropoietin and erythropoietin receptor expression following experimental spinal cord injury supports therapy by exogenous erythropoietin. Neurosurgery 56:821-827, 2005
8. Ihle JN, Witthuhn B, Tang B, Yi T, Quelle FW: Cytokine receptors and signal transduction. Baillieres Clin Haematol 7:17-48, 1994
9. Leyland-Jones B: Breast cancer trial with erythropoietin terminated unexpectedly. Lancet Oncol 4:459-460, 2003
10. Semenza G: Hypoxia, clonal selection, and the role of HIF-1 in tumor progression. Crit Rev Biochem Mol Biol 35:71-103, 2000
11. Suzuki K: Use of recombinant human erythropoietin as adjuvant therapy for blood banking for autotransfusion in dogs. Vet J 155:239-244, 1998
12. Wojchowski DM, Gregory RC, Miller CP, Pandit AK, Pircher TJ: Signal transduction in the erythropoietin receptor system. Exp Cell Res 253:143-156, 1999
13. Yamauchi A, Ohta T, Okada T, Mochizuki M, Nishimura R, Matsunaga S, Nakayama H, Doi K, Sasaki N: Secondary erythrocytosis associated with schwannoma in a dog. J Vet Med Sci 66:1605-1608, 2004
14. Yasuda Y, Fujita Y, Matsuo T, Koinuma S, Hara S, Tazaki A, Onozaki M, Hashimoto M, Musha T, Ogawa K, Fujita H, Nakamura Y, Shiozaki H, Utsumi H: Erythropoietin regulates tumour growth of human malignancies. Carcinogenesis 24:1021-1029, 2003